| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.399 | 0 | 0 | 0 | 0 | 0 | 0 | 87.918 | 78.972 | 0 |
| Total Income - EUR | 5.399 | 0 | 0 | 0 | 0 | 0 | 0 | 88.121 | 79.113 | 0 |
| Total Expenses - EUR | 993 | 557 | 33 | 39 | 194 | 2 | 0 | 13.618 | 13.095 | 3.752 |
| Gross Profit/Loss - EUR | 4.406 | -557 | -33 | -39 | -194 | -2 | 0 | 74.502 | 66.019 | -3.752 |
| Net Profit/Loss - EUR | 4.244 | -557 | -33 | -39 | -194 | -2 | 0 | 73.641 | 65.245 | -3.752 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Tweescience S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.551 | 36 | 3 | 2 | 2 | 0 | 0 | 75.692 | 67.363 | 1.778 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 57.383 | 52.553 | 330 |
| Cash | 4.551 | 36 | 3 | 2 | 2 | 0 | 0 | 18.308 | 14.810 | 1.447 |
| Shareholders Funds | 4.289 | -503 | -528 | -557 | -741 | -728 | -712 | 72.926 | 64.532 | 372 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 297 | 540 | 530 | 559 | 742 | 728 | 712 | 2.787 | 2.832 | 1.406 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1812 - 1812" | |||||||||
| CAEN Financial Year |
1812
|
|||||||||
Comments - Tweescience S.r.l.